Dicerna Pharmaceuticals

-$0.05 (-0.12%) As of 2:47 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell DRNA and other ETFs, options, and stocks.

About DRNA

Dicerna Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in discovering, developing and commercializing medicines that are designed to leverage ribonucleic acid interference (RNAi) to selectively silence genes that cause or contribute to disease. The firm uses its proprietary GalXC RNAi technology platform to build a pipeline in these therapeutic areas.

CEO
Douglas M. Fambrough
Employees
302
Headquarters
Lexington, Massachusetts
Founded
2006

DRNA Key Statistics

Market cap
2.98B
Price-Earnings ratio
—
Dividend yield
—
Average volume
9.23M
High today
$38.26
Low today
$38.10
Open price
$38.13
Volume
434.21K
52 Week high
$40.14
52 Week low
$19.06

DRNA Earnings

-$0.53
-$0.22
$0.10
$0.41
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
— per share
Actual
Expected Feb 24, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure